{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Increasing number of hemophilia drug makers and specialty pharmacies are employing patients and their relatives to gain sales advantage and increase revenue; ethical issues are raised. ", "type_of_material": "News", "word_count": "1254", "lead_paragraph": "When hemophiliacs make their living by selling lucrative hemophilia drugs, patient advocates say it creates a dangerous conflict of interest.", "pub_date": "2016-01-14T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Hemophilia Patient or Drug Seller? Dual Role Creates Ethical Quandary", "print_headline": "The Patient&#8217;s Sales Pitch "}, "snippet": "When hemophiliacs make their living by selling lucrative hemophilia drugs, patient advocates say it creates a dangerous conflict of interest.", "multimedia": [{"height": 126, "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 398, "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "398", "xlarge": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/01/14/business/hemophilia-patient-or-drug-seller-dual-role-creates-ethical-quandary.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Hemophilia", "name": "subject"}, {"rank": "11", "is_major": "N", "value": "Novo Nordisk A/S", "name": "organizations"}, {"rank": "12", "is_major": "N", "value": "Baxalta Inc.", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Conflicts of Interest", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Blood", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Ethics and Official Misconduct", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Hemophilia of North Carolina", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "National Hemophilia Foundation", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "MedfusionRx LLC", "name": "organizations"}, {"rank": "9", "is_major": "N", "value": "Bayer AG", "name": "organizations"}, {"rank": "10", "is_major": "N", "value": "Pfizer Inc", "name": "organizations"}], "blog": [], "_id": "569694b938f0d865e6c34836", "source": "The New York Times"}